Birdwatch Archive

Birdwatch Note

2024-03-26 13:21:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

このポストで取り上げられている健康被害救済制度の被害認定に当たっては「厳密な医学的な因果関係までは必要とせず、接種後の症状が予防接種によって起こることを否定できない場合も対象とする」という方針で審査が行われています。 https://www.mhlw.go.jp/content/10900000/001017433.pdf その為、救済制度の認定数が多いからと言って、それがワクチンに起因するものとは限りません。 今回のコロナワクチンについても、臨床試験の結果などに基づいて有効性、安全性、品質についての審査が行われ、承認されています。 https://www.cov19-vaccine.mhlw.go.jp/qa/0001.html

Written by C78B58351151F1E7E29379FA561D73B7CC128D82B5157FE021D11C9BE177D8BC
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1772594722768560140

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1772614976915821038
  • noteId - 1772614976915821038
  • participantId -
  • noteAuthorParticipantId - C78B58351151F1E7E29379FA561D73B7CC128D82B5157FE021D11C9BE177D8BC Participant Details
  • createdAtMillis - 1711459318747
  • tweetId - 1772594722768560140
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 0
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • このポストで取り上げられている健康被害救済制度の被害認定に当たっては「厳密な医学的な因果関係までは必要とせず、接種後の症状が予防接種によって起こることを否定できない場合も対象とする」という方針で審査が行われています。 https://www.mhlw.go.jp/content/10900000/001017433.pdf その為、救済制度の認定数が多いからと言って、それがワクチンに起因するものとは限りません。 今回のコロナワクチンについても、臨床試験の結果などに基づいて有効性、安全性、品質についての審査が行われ、承認されています。 https://www.cov19-vaccine.mhlw.go.jp/qa/0001.html

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-26 13:21:58 UTC
(1711459318747)
2024-03-26 22:58:00 UTC
(1711493880866)
CURRENTLY_RATED_HELPFUL 2024-03-28 02:49:05 UTC
(1711594145171)
NEEDS_MORE_RATINGS 2024-03-26 22:58:00 UTC
(1711493880866)
CURRENTLY_RATED_HELPFUL

Note Ratings

rated at rated by
2024-03-26 18:07:17 -0500 Rating Details
2024-03-26 18:00:48 -0500 Rating Details
2024-03-26 18:00:38 -0500 Rating Details
2024-03-26 17:56:33 -0500 Rating Details
2024-03-26 17:38:44 -0500 Rating Details
2024-03-26 17:34:57 -0500 Rating Details
2024-03-26 17:30:42 -0500 Rating Details
2024-03-26 17:14:24 -0500 Rating Details
2024-03-26 16:43:51 -0500 Rating Details
2024-03-26 14:26:38 -0500 Rating Details
2024-03-26 13:27:09 -0500 Rating Details
2024-03-26 13:24:40 -0500 Rating Details
2024-03-26 13:22:35 -0500 Rating Details
2024-03-26 12:33:17 -0500 Rating Details
2024-03-26 10:47:37 -0500 Rating Details
2024-03-26 10:45:29 -0500 Rating Details
2024-03-26 10:41:08 -0500 Rating Details
2024-03-26 09:32:45 -0500 Rating Details
2024-03-26 09:30:25 -0500 Rating Details
2024-03-26 09:00:58 -0500 Rating Details
2024-03-26 08:57:23 -0500 Rating Details
2024-03-26 08:54:54 -0500 Rating Details
2024-03-26 08:54:25 -0500 Rating Details
2024-03-26 08:52:19 -0500 Rating Details
2024-03-26 08:48:44 -0500 Rating Details
2024-03-26 08:41:26 -0500 Rating Details
2024-03-26 08:39:12 -0500 Rating Details
2024-03-26 08:32:27 -0500 Rating Details
2024-03-26 08:29:58 -0500 Rating Details
2024-03-26 08:28:12 -0500 Rating Details
2024-03-27 12:22:00 -0500 Rating Details
2024-03-27 12:08:20 -0500 Rating Details
2024-03-27 06:59:03 -0500 Rating Details
2024-03-27 04:53:15 -0500 Rating Details
2024-03-27 03:50:01 -0500 Rating Details
2024-03-27 03:21:22 -0500 Rating Details
2024-03-26 23:58:49 -0500 Rating Details
2024-03-26 22:52:16 -0500 Rating Details
2024-03-26 20:58:06 -0500 Rating Details
2024-03-26 18:17:11 -0500 Rating Details
2024-03-26 17:54:39 -0500 Rating Details
2024-03-26 17:54:33 -0500 Rating Details
2024-03-26 15:50:07 -0500 Rating Details
2024-03-26 15:41:16 -0500 Rating Details
2024-03-26 15:10:34 -0500 Rating Details
2024-03-26 14:48:12 -0500 Rating Details
2024-03-26 13:59:37 -0500 Rating Details
2024-03-26 10:47:45 -0500 Rating Details
2024-03-26 09:53:16 -0500 Rating Details
2024-03-26 09:09:26 -0500 Rating Details
2024-03-26 09:06:01 -0500 Rating Details
2024-03-26 08:54:10 -0500 Rating Details
2024-03-26 08:47:12 -0500 Rating Details
2024-03-26 08:34:34 -0500 Rating Details
2024-03-26 08:33:40 -0500 Rating Details
2024-03-26 08:31:33 -0500 Rating Details
2024-03-27 23:04:09 -0500 Rating Details
2024-03-27 17:19:15 -0500 Rating Details
2024-03-27 16:26:59 -0500 Rating Details
2024-03-27 07:27:07 -0500 Rating Details
2024-03-27 00:57:03 -0500 Rating Details
2024-03-26 22:56:10 -0500 Rating Details
2024-03-26 22:30:32 -0500 Rating Details
2024-03-30 00:03:55 -0500 Rating Details
2024-03-28 20:29:26 -0500 Rating Details
2024-04-08 04:02:15 -0500 Rating Details
2024-03-27 01:33:20 -0500 Rating Details
2024-03-26 22:10:52 -0500 Rating Details